Menu Search

United States

S&P 500Last 5 days
Last price6,688.46
Dow Jones Industrial AverageLast 5 days
Last price46,397.89
NASDAQ CompositeLast 5 days
Last price22,660.01
Bloomberg Commodity IndexLast 5 days
Last price104.63
NYSE CompLast 5 days
Last price21,564.54
FTSE All-World $Last 5 days
Last price648.92
Dow Jones Total Stock MarketLast 5 days
Last price66,145.67
FT Wilshire 5000 IndexLast 5 days
Last price66,847.84
MSCI International ACWI Net Index USLast 5 days
Last price540.07

Loading...

USD overview

PairLatest rateToday's change1 year change
USDGBP0.7438
GBP		-0.0008 / -0.11%--
USDEUR0.852
EUR		-0.0007 / -0.08%--
USDJPY147.93
JPY		-0.65 / -0.44%--
USDAUD1.51
AUD		-0.008 / -0.53%--
USDCAD1.39
CAD		0.001 / 0.07%--
USDCNY7.12
CNY		-0.0004 / -0.01%--
USDCHF0.7961
CHF		-0.0013 / -0.16%--

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of United States in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the S&P 500 with the highest percent gain over one day.
ListingLastChangeVolume
Pfizer IncPFE:NYQ25.48
USD		+1.63
+6.83%		163.83m
Merck & Co IncMRK:NYQ83.93
USD		+5.35
+6.81%		21.41m
Danaher CorpDHR:NYQ198.26
USD		+12.20
+6.56%		7.73m
Bio-Techne CorpTECH:NSQ55.63
USD		+3.40
+6.51%		3.64m
Charles River Laboratories International IncCRL:NYQ156.46
USD		+9.47
+6.44%		1.05m
Freeport-McMoRan IncFCX:NYQ39.22
USD		+2.10
+5.66%		38.93m
IQVIA Holdings IncIQV:NYQ189.94
USD		+9.22
+5.10%		1.60m
Eli Lilly and CoLLY:NYQ763.00
USD		+36.49
+5.02%		6.19m
Thermo Fisher Scientific IncTMO:NYQ485.02
USD		+22.98
+4.97%		4.36m
Robinhood Markets IncHOOD:NSQ143.18
USD		+6.46
+4.72%		50.41m
Data delayed at least 15 minutes, as of Sep 30 2025 21:02 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.